Ready to get started? The workout is designed by Pilates instructor and physiotherapist, Lilly Sabri. It’s an intense, ...

Here are the year’s notable fiction, poetry and nonfiction, chosen by the staff of The New York Times Book Review. By The New York Times Books Staff In her memoir, the former German chancellor ...

— Lilly to Develop Two Targets Identified and Validated Using Verge Genomics’ AI-Enabled, All-in-Human CONVERGE® Platform — Demonstration of the Robust Predictive Power of CONVERGE® - 83% ...

Eli Lilly has seen tremendous growth from its new GLP-1 drugs, which people have been using for weight loss. Sales growth should continue as the company increases production and looks to win ...

Revelations about a relationship between the author and a girl who was 16 when they met shocked readers, but not scholars of his work. Now there’s a debate about how much she influenced his ...

After years in development, the FDA has started its review of Pfizer and Eli Lilly’s new painkiller tanezumab, one of two remaining drugs in the ill-fated nerve growth factor (NGF) inhibitor class.

You may have seen the following disclosure on all of our business, commercial, and financial product and services reviews and recommendations. It reads: "We independently evaluate all recommended ...

Lilly’s drug could be the first to add cluster headache to its label however, with the FDA starting a speedy priority review of the drug having awarded it a breakthrough designation in cluster ...

Amgen stock tumbled Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's Zepbound. More than seven million additional Americans could get ...